Working… Menu
Trial record 18 of 18 for:    pralatrexate AND Vitamin B

Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn®

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01820091
Recruitment Status : Withdrawn
First Posted : March 28, 2013
Last Update Posted : September 5, 2013
Information provided by (Responsible Party):
Spectrum Pharmaceuticals, Inc

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : April 2015
Estimated Study Completion Date : April 2015